Market Overview

Medtronic Narrows FY13 EPS Outlook

Share:
Related MDT
Medtronic Remains A Top Pick At UBS Following HeartWare Deal
Medtronic Reveals Beacon Heart Failure Management Service
The Vetr community has downgraded $MDT to 3-Stars (Vetr)

In a presentation to investors, Medtronic, Inc. (NYSE: MDT) today updated diluted earnings per share (EPS) guidance for fiscal year 2013.

The Company tightened its fiscal 2013 diluted EPS guidance range to $3.66 to $3.70 from the previously stated range of $3.62 to $3.70. The new range implies annual EPS growth of 6 to 7%.

Posted-In: News Guidance

 

Related Articles (MDT)

View Comments and Join the Discussion!